Brenneman Jehrod Burnett,Ginn John David,Lowe Michael D.,Sarko Christopher Ronald,Tasber Edward S.,Zhang Zhonghua
申请号：
NZ70398913
公开号：
NZ703989A
申请日:
2013.09.03
申请国别(地区):
NZ
年份:
2017
代理人:
摘要：
The present invention relates to soluble guanylate cyclase activating compounds of formula (I) and pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4, R5, R6 and R7 are as defined herein. The invention also relates to pharmaceutical compositions comprising these compounds, and methods of using these compounds in the treatment of various diseases and disorders alleviated by sGC activation or potentiation.
